Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Zhao, Ming-Tao  [Clear All Filters]
Journal Article
Zhao M-T, Shao N-Y, Garg V. Subtype-specific cardiomyocytes for precision medicine: where are we now?. Stem Cells. 2020.
Liu C, Shen M, Tan WLW, Chen IY, Liu Y, Yu X, Yang H, Zhang A, Liu Y, Zhao M-T, et al. Statins improve endothelial function via suppression of epigenetic-driven EndMT. Nat Cardiovasc Res. 2023;2(5):467-485.
Ye S, Wang C, Xu Z, Lin H, Wan X, Yu Y, Adhicary S, Zhang JZ, Zhou Y, Liu C, et al. Impaired Human Cardiac Cell Development due to NOTCH1 Deficiency. Circ Res. 2022.
Cunningham D, Stanberry I, Ye S, Alonzo M, Zhao M-T, Garg V, Lilly B. Generation of iPSC line NCHi012-A from a patient with Alagille syndrome and heterozygous pathogenic variant in the JAG1 gene. Stem Cell Res. 2023;71:103177.
Yu Y, Alonzo M, Ye S, Fang A, Manickam K, Garg V, Zhao M-T. Generation of an induced pluripotent stem cell line (NCHi010-A) from a 6-year-old female with down syndrome and without congenital heart disease. Stem Cell Res. 2023;71:103155.
Alonzo M, Ye S, Beckman B, Texter K, Garg V, Zhao M-T. Creation of iPSC line NCHi004-A from a patient with down syndrome and congenital heart defects. Stem Cell Res. 2023;71:103156.
Yu Y, Wang C, Ye S, Xu Z, Lin H, Texter K, Shukla V, Ghadiali S, Ma Q, Garg V, et al. Abnormal Progenitor Cell Differentiation and Cardiomyocyte Proliferation in Hypoplastic Right Heart Syndrome. Circulation. 2024;149(11):888-891.